These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 344222)

  • 1. Immunity to experimental renal candidiasis in rats.
    Rogers TJ; Balish E
    Infect Immun; 1978 Feb; 19(2):737-40. PubMed ID: 344222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats.
    Rogers TJ; Balish E
    Infect Immun; 1978 Apr; 20(1):142-50. PubMed ID: 352927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis.
    Raska M; Beláková J; Wudattu NK; Kafková L; Růzicková K; Sebestová M; Kolár Z; Weigl E
    Folia Microbiol (Praha); 2005; 50(1):77-82. PubMed ID: 15954537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.
    Giger DK; Domer JE; McQuitty JT
    Infect Immun; 1978 Feb; 19(2):499-509. PubMed ID: 344213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of mice against candidiasis.
    Jensen J; Warner T; Johnson C; Balish E
    J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney.
    Ramani K; Garg AV; Jawale CV; Conti HR; Whibley N; Jackson EK; Shiva SS; Horne W; Kolls JK; Gaffen SL; Biswas PS
    PLoS Pathog; 2016 Nov; 12(11):e1005952. PubMed ID: 27814401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis.
    Lionakis MS; Fischer BG; Lim JK; Swamydas M; Wan W; Richard Lee CC; Cohen JI; Scheinberg P; Gao JL; Murphy PM
    PLoS Pathog; 2012; 8(8):e1002865. PubMed ID: 22916017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18β-glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract.
    Kim J; Joo I; Kim H; Han Y
    Phytomedicine; 2013 Aug; 20(11):951-5. PubMed ID: 23746951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
    Segal E
    Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
    Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.
    MacCallum DM; Castillo L; Brown AJ; Gow NA; Odds FC
    PLoS One; 2009 Jul; 4(7):e6420. PubMed ID: 19641609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans: pathogenesis, immunity and host defence.
    Ashman RB
    Res Immunol; 1998; 149(4-5):281-8; discussion 494-6. PubMed ID: 9720946
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental Candida albicans infection in conventional mice and germfree rats.
    Rogers T; Balish E
    Infect Immun; 1976 Jul; 14(1):33-8. PubMed ID: 780278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immunization with formalin killed cells in complete Freund's adjuvant in experimental candidosis.
    Banerjee U; Mohapatra LN; Kumar R
    Indian J Med Res; 1985 May; 81():454-8. PubMed ID: 4030030
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired immunity to systemic candidiasis in immunodeficient mice.
    Cantorna MT; Balish E
    J Infect Dis; 1991 Nov; 164(5):936-43. PubMed ID: 1940472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective antigens and mechanisms of anti-Candida immunity.
    Antonio C
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.